Characteristics, Risk Factors, and Adverse Outcomes of Hyperkalemia in Acute-on-Chronic Liver Failure Patients
Table 5
Independent factors associated with 90-day mortality (a) in patients with hyperkalemia and (b) in all ACLF patients.
(a)
Effect
Estimate
OR (95CI)
Standard error
Wald X2
P-value
Acute kidney injury
2.43
11.36(1.838-70.186)
0.929
6.837
0.009
INR
2.103
8.19(1.668-40.202)
0.812
6.707
0.010
(b)
Effect
Estimate
OR (95CI)
Standard error
Wald X2
P-value
Hepatic encephalopathy
1.206
3.34(2.146-5.195)
0.226
28.560
<0.001
Gastrointestinal bleeding
0.693
2.00(1.207-3.315)
0.258
7.231
0.007
Acute kidney injury
0.853
2.35(1.482-3.714)
0.234
13.241
<0.001
Hyperkalemia
1.091
2.98(1.539-5.760)
0.337
10.505
0.001
TBIL
0.004
1.00(1.002-1,006)
0.001
13.893
<0.001
INR
0.568
1.77(1.230-2.532)
0.184
9.526
0.002
MELD
-0.110
0.90(0.826-0.973)
0.042
6.888
0.009
CLIF-SOFA
0.176
1.19(1.065-1.335)
0.058
9.307
0.002
INR, international normalized ratio; TBIL, total bilirubin; MELD, Model for End-Stage Liver Disease; CLIF-SOFA, chronic liver failure-sequential organ failure assessment.
